Упрощенная HTML-версия
147
219. Lloyd Jones D.M. Lifetime risk of developing coronary heart disease /
D.M. Lloyd Jones, M.G. Larson, A. Beiser et al. // Lancet. – 1999. – № 353. – Р.
89-92.
220. Marrugat J. Mortality differences between men and women following
first myocardial infarction. RESCATE Investigators. Recursos Empleados enel
Sindrome Coronario Agudo y Tiempo de Espera / J. Marrugat, J. Sala, R. Masia et
al. // JAMA. – 1998. – Vol. 280 (16). – Р. 1405-1409.
221. Martsevich S.Y. Development of tolerance to nifedipine in patients with
stable angina pectoris / S.Y.
t al. //
Br. J. Clin. Pharmacol. – 1990. – Vol. 29 (3). – P. 339-346.
222. Mason P.J. Aspirin resistance: current concepts / P.J. Mason, J.E.
Freedman, A.K. Jacobs // Rev. Cardiovasc. Med. – 2004. – Vol. 5 (3). – Р. 156-
163.
223. Matetzky S. Clopidogrel resistance is associated with increased risk of
recurrent atherothrombotic events in patients with acute myocardial infarction / S.
Matetzky, B. Shenkman, V. Guetta et al. // Circulation. – 2004. – Vol. 109. – Р.
3171 – 3175.
224. McAdam B.F. Systemic biosynthesis of prostacyclin by cyclooxygenase
(COX)-2: the human pharmacology of a selective inhibitor of COX-2 / B.F.
McAdam, F. Catella-Lawson, I.A. Mardini et al. // FitzGerald GA. Proc Natl Acad
Sci U S A. – 1999. – Vol. 96 (1). – Р. 272-277.
225. Michelson A.D. Aspirin resistance: position paper of the Working Group
on Aspirin Resistance, Platelet Physiology Subcommittee of the Scientific and
Standardization Committee of the International Society on Thrombosis and
Haemostasis / A.D. Michelson, M. Cattaneo, J.W. Eikelboom // J. Thromb.
Haemost. – 2005. – Vol. 3 (6). – Р. 1309-1311.
226. Michelson A.D. Platelet function testing in cardiovascular diseases /
A.D. Michelson // Circulation. – 2004. – Vol. 110 (19). – p. 489-493.
227. Mombouli J.V. Endothelial Dysfunction: from physiology to therapy /
J.V. Mombouli, P.M. Vanhoutte // J. Moll. Cell. Cardiol. – 1999. – № 31. – Р. 61-
74.